REQUEST A DEMO
Total
USD $0.00
Search more companies

Azeta Vaistine, UAB (Lithuania)

Main Activities: Pharmacies and Drug Stores
Full name: Azeta Vaistine, UAB Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Azeta Vaistine, UAB is a company based in Lithuania, with its head office in Vilnius. The enterprise currently operates in the Pharmacies and Drug Stores sector. Azeta Vaistine, UAB was incorporated on September 21, 2020. 32 (2025) employees currently work for Azeta Vaistine, UAB. The company’s latest financial report indicates a net sales revenue increase of 16.02% in 2024. Azeta Vaistine, UAB’s net profit margin increased by 2.87% in 2024.

Headquarters
Savanoriu pr. 16-701
Vilnius; Vilnius county; Postal Code: LT-03159

Contact Details: Purchase the Azeta Vaistine, UAB report to view the information.

Basic Information
Total Employees:
Purchase the Azeta Vaistine, UAB report to view the information.
Registered Capital:
Purchase the Azeta Vaistine, UAB report to view the information.
Financial Auditors:
Purchase the Azeta Vaistine, UAB report to view the information.
Incorporation Date:
September 21, 2020
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Azeta Vaistine, UAB report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
16.02%
Total operating revenue
16.02%
Net Profit (Loss) for the Period
744.55%
Total equity
416.1%
Net Profit Margin
2.87%
Return on Equity (ROE)
31.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?